Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype

Neuroscience

Volumn 122, Issue 1, 2003, Pages 103-110

  Glockner F ^a   Ohm, T G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein D; Apolipoprotein E genotype; Braak staging

Indexed keywords

APOLIPOPROTEIN D; APOLIPOPROTEIN E4; LIPOCALIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; NERVE REGENERATION; NEUROPATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SAMPLING;

EID: 0142195836     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00529-3     Document Type: Article

References (35)

1. Ackermann H. BIAS a programme package for biometrical analysis of samples. Comp Stat. 11:1991;223-224.
2. Balbin M., Freije J.M., Fueyo A., Sanchez L.M., Lopez-Otin C. Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease. Biochem J. 271:1990;803-807.
3. Belloir B., Kövari E., Surini-Demiri M., Savioz A. Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res. 64:2001;61-69.
4. Boyles J.K., Notterpek L.M., Anderson L.J. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J Biol Chem. 265:1990;17805-17815.
5. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol Berl. 82:1991;239-259.
6. Drayna D., Fielding C., Mclean J., Baer B., Castro G., Chen E., Comstock L., Henzel W., Kohr W., Rhee L. Cloning and expression of human apolipoprotein D cDNA. J Biol Chem. 261:1986;16535-16539.
7. Flower D.R. The lipocalin protein family, structure and function. Biochem J. 318:1996;1-14.
8. Franz G., Reindl M., Patel S.C., Beer R., Unterrichter I., Berger T., Schmutzhard E., Poewe W., Kampfl A. Increased expression of apolipoprotein D following experimental traumatic brain injury. J Neurochem. 73:1999;1615-1625.
9. Glöckner F., Meske V., Ohm T.G. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease. Neuroscience. 114:2002;11103-11114.
10. Haagensen D.E., Mazoujian G. Biochemistry and Immunohistochemistry of fluid proteins of the breast in gross cystic disease. Haagensen C.D. Diseases of the breast. 3rd edn: 1986; 500 Saunders, Philadelphia.
11. Harr S.D., Uint L., Hollister R., Hyman B.T., Mendez A.J. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem. 66:1996;2429-2435.
12. Kalman J., McConathy W., Araoz C., Kasa P., Lacko A.G. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res. 22:2000;330-336.
13. Kesner L., Yu W.S., Bradlow H.L., Breed C.W., Fleisher M. Proteases in cyst fluid from human gross cyst breast disease. Cancer Res. 48:1988;6379-6383.
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
15. Lea O.A. Binding properties of progesterone-binding Cyst protein (PBCP). Steroids. 52:1988;337-338.
16. McConathy W.J., Alaupovic P. Isolation and partial characterization of apolipoprotein D, a new protein moiety of the human plasma lipoprotein system. FEBS Lett. 37:1973;178-182.
17. Montpied P., de Bock F., Lerner Natoli M., Bockaert J., Rondouin G. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epilepsy Res. 35:1999;135-146.
18. Morais Cabral J.H., Atkins G.L., Sanchez L.M., Lopez Boado Y.S., Lopez O.-C., Sawyer L. Arachidonic acid binds to apolipoprotein D, implications for the protein's function. FEBS Lett. 366:1995;53-56.
19. Ohm T.G., Müller H., Braak H., Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience. 64:1995;209-217.
20. Ohm T.G., Scharnagl H., Marz W., Bohl J. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol Berl. 98:1999;273-280.
21. Ong W.Y., He Y., Suresh S., Patel S.C. Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience. 79:1997;359-367.
22. Pearlman W.H., Gueriguian J.L., Sawyer M.E. A specific progesterone-binding component of human breast cyst fluid. J Biol Chem. 248:1973;5736-5741.
23. Peitsch M.C., Boguski M.S. Is apolipoprotein D a mammalian bilin-binding protein? New Biol. 2:1990;197-206.
24. Provost P.R., Weech P.K., Tremblay N.M., Marcel Y.L., Rassart E. Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D. J Lipid Res. 31:1990;2057-2065.
25. Rassart E., Bedirian A., Do-Carmo S., Guinard O., Sirois J., Terrisse L., Milne R. Apolipoprotein D. Biochim Biophys Acta. 1482:2000;185-198.
26. Saunders A.M., Strittmatter W.J., Schmechel D., George Hyslop P.H., Pericak Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper M.-D., Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
27. Smith K.M., Lawn R.M., Wilcox J.N. Cellular localization of apolipoprotein D and lecithin, cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization. J Lipid Res. 31:1990;995-1004.
28. Spreyer P., Schaal H., Kuhn G., Rothe T., Unterbeck A., Olek K., Müller H.W. Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J. 9:1990;2479-2484.
29. Steyrer E., Kostner G.M. Activation of lecithin-cholesterol acyltransferase by apolipoprotein D, comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. Biochim Biophys Acta. 958:1988;484-491.
30. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 90:1993;1977-1981.
31. Sun Q., Disher M.J., Rustad T., Telian S.A., Andrews P.C. AP30, a differential protein marker for perilymph and cerebrospinal fluid in middle ear fluid, has been purified and identified as human apolipoprotein D. Biochim Biophys Acta. 1384:1998;405-413.
32. Terrisse L., Poirier J., Bertrand P., Merched A., Visvikis S., Siest G., Milne R., Rassart E. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem. 71:1998;1643-1650.
33. Terrisse L., Seguin D., Bertrand P., Poirier J., Milne R., Rassart E. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Brain Res Mol Brain Res. 70:1999;26-35.
34. Thomas E.A., Sautkulis L.N., Criado J.R., Games D., Sutcliffe J.G. Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice. J Neurochem. 79:2001;1059-1064.
35. Zeng C., Spielman A.I., Vowels B.R., Leyden J.J., Biemann K., Preti G. A human axillary odorant is carried by apolipoprotein D. Proc Natl Acad Sci USA. 93:1996;6626-6630.